Press releases

16/12/2015 18:00
|

Further advance for Quantum Genomics in securing animal health partnership for heart failure treatment

25/11/2015 17:45
|

Quantum Genomics' Scientific Advisory Board recommends next multicentric clinical trials in Europe and United States

15/10/2015 19:15
|

2015 Half-year results - Update on latest developments

06/10/2015 18:00
|

Positive opinion from Monitoring Board to continue protocol as planned, for Phase IIa clinical trial under way for high blood pressure

08/09/2015 18:00
|

Phase IIa clinical trial for high blood pressure : 50% enrolment four months ahead of schedule and Supervisory Board meeting coming up

27/07/2015 18:00
|

Quantum Genomics announces the appointment of Professor Faiez Zannad as its heart failure consultant

29/06/2015 18:45
|

Quantum Genomics obtains positive results with heart failure study in dogs

02/06/2015 17:45
|

Quantum Genomics at the 2015 BIO International Convention, June 15-18 in Philadelphia, and at the French Life Sciences Days, June 17-18, 2015, in New York

22/04/2015 18:45
|

2014 Annual financial report now available - Update on Q1 2015 activity

16/04/2015 17:45
|

Quantum Genomics to meet investors at the European Smallcap Event, April 27 and 28, 2015

17/03/2015 17:45
|

Creation of a joint Inserm-Quantum Genomics laboratory at the Collège de France backed by the French National Agency for Research (ANR)

03/03/2015 17:45
|

First patients recruited for Phase IIa trial of drug candidate QGC001

25/02/2015 19:00
|

Quantum Genomics reports total capital increase after stabilization period: EUR 12.9 million

17/02/2015 11:00
|

Remarkable uptake in Quantum Genomics IPO* : EUR 11.2 million raised

12/01/2015 08:30
|

Quantum Genomics at J.P. Morgan 34th annual healthcare conference